Teladoc Health Reports Fourth-Quarter and Full-Year 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq end lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Teladoc (TDOC) PT Lowered to $70 at Cantor Fitzgerald
February 28, 2019 9:00 AM ESTCantor Fitzgerald analyst Steven Halper lowered the price target on Teladoc (NYSE: TDOC) to $70.00 (from $83.00) while maintaining a Neutral rating following the company's 4Q earnings report. Revenue was $123M vs. consensus of $120M. Adjusted EBITDA was $5.8M vs. $2.4M a year... More
